CanSino Biologics (HKSE:06185) FCF Yield % : -7.39 (As of May. 14, 2024)

View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, CanSino Biologics's Trailing 12-Month Free Cash Flow is HK$-693.1 Mil, and Market Cap is HK$9,369.9 Mil. Therefore, CanSino Biologics's FCF Yield % for today is -7.39%.

The historical rank and industry rank for CanSino Biologics's FCF Yield % or its related term are showing as below:

HKSE:06185' s FCF Yield % Range Over the Past 10 Years
Min: -17.44 Med: -1.54 Max: 2.52
Current: -7.39

During the past 8 years, the highest FCF Yield % of CanSino Biologics was 2.52%. The lowest was -17.44%. And the median was -1.54%.

HKSE:06185's FCF Yield % is ranked worse than
71.97% of 1081 companies
in the Drug Manufacturers industry
Industry Median: -0.55 vs HKSE:06185: -7.39

CanSino Biologics's FCF Margin % for the quarter that ended in Mar. 2024 was -212.29%.

CanSino Biologics FCF Yield % Historical Data

The historical data trend for CanSino Biologics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics FCF Yield % Chart

CanSino Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-2.43

-2.01

2.23

-20.03

-28.66

CanSino Biologics Quarterly Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial													5.71	-6.99	-9.14	-12.25	-26.76

Competitive Comparison of CanSino Biologics's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, CanSino Biologics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanSino Biologics's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanSino Biologics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where CanSino Biologics's FCF Yield % falls into.

CanSino Biologics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

CanSino Biologics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1669.896	/	5827.4475
	=	-28.66%

CanSino Biologics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-263.548	*	4	/	3939.404
	=	-26.76%

CanSino Biologics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

CanSino Biologics FCF Yield % Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

CanSino Biologics (HKSE:06185) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (HKSE:06185) » Definitions » FCF Yield %

Traded in Other Exchanges

CASBF:USA CJH:Germany 688185:China

Address

185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN

Website

https://www.cansinotech.com

CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.

CanSino Biologics (HKSE:06185) Headlines

No Headlines